文献速递生殖医学母胎医学

扩展性携带者筛查对妊娠相关诊疗及个体健康临床意义的评估

Clinical implications of expanded carrier screening for pregnancy-related care and individual health.
PubMed 文献 · Fertil Steril · 2025-08-25

1.7%为纯合或复合杂合可能患病,3.9%结果涉及个体健康。在双方均完成筛查的905对夫妇中,58对(6.4%)携带相同疾病,其中21对(2.3%)为临床显著致病组合并建议单基因病植入前遗传学检测。

要点

  • 54例(1.7%)为纯合或复合杂合,可能患病。
  • 68例(2.2%)为高风险杂合携带者,影响个体健康。

核心结论

  • 小部分(1.7%)扩展性携带者筛查结果影响临床生育诊疗,触发体外受精联合单基因病植入前遗传学检测的建议。
  • 较大比例(3.9%)结果涉及患者个体健康,可能在知情同意过程中未被充分告知,并可能影响人寿和残疾保险等福利资格。

研究设计与样本

  • 单中心、回顾性、队列研究,纳入2018年1月至2020年12月接受扩展性携带者筛查的3136例患者。
  • 所有患者使用同一扩展性携带者筛查,包含283个基因。

主要发现

  • 54例(1.7%)为隐性遗传病纯合或复合杂合。
  • 68例(2.2%)为隐性遗传病高风险杂合携带者:戈谢病34例、家族性高胆固醇血症14例、延胡索酸酶缺乏症9例、共济失调-毛细血管扩张症7例、脆性X前突变4例。
  • 10例女性X连锁疾病携带者(0.4%)。
  • 在双方均完成扩展性携带者筛查的905对夫妇中,58对(6.4%)携带相同遗传病,其中21对(2.3%)为临床显著致病组合并建议单基因病植入前遗传学检测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the incidence of expanded carrier screening (ECS) results with possible clinical implications on patient health and/or pregnancy-related treatment planning. DESIGN: Single academic center, retrospective, cohort study. SUBJECTS: A total of 3,136 patients underwent ECS between January 2018 and December 2020. EXPOSURE: All patients were screened using the same ECS, comprising 283 genes. MAIN OUTCOME MEASURES: Rates of positive ECS results and carrier-carrier couples were reported, excluding carrier-carrier couples without a reproductive risk for a serious clinical outcome (i.e., alpha thalassemia single-gene deletions). Results with possible ramifications for an individual patient's health were recorded. This included individuals identified through ECS to be potentially affected with a genetic condition due to homozygous or compound heterozygous findings, and those with heterozygous findings associated with a personal health risk, such as elevated risk for premature ovarian insufficiency, metabolic crisis, neurological disease, cardiovascular disease, or malignancy. RESULTS: Expanded carrier screening was performed and resulted in 3,136 patients; 2,280 (72.7%) carried at least one condition. Fifty-four patients (1.7%) were homozygous or compound heterozygous for a recessive genetic condition. Another 68 patients (2.2%) were high-risk heterozygote carriers of a recessive disease: Gaucher (n = 34), familial hypercholesterolemia (n = 14), fumarase deficiency (n = 9), ataxia-telangiectasia (n = 7), and fragile X premutation (n = 4). Ten female carriers of X-linked conditions were identified (0.4%). When restricting analysis to couples who both completed ECS (n = 905 couples), 58 couples (6.4%) carried the same genetic condition, although only 21 (2.3%) were considered clinically significant disease-causing combinations and recommended for preimplantation genetic testing for monogenic conditions. CONCLUSION: A small proportion (1.7%) of total ECS results impact clinical fertility care by triggering recommendations for in vitro fertilization with preimplantation genetic testing for monogenic conditions. A larger proportion of results (3.9%) had implications for patients' personal health, which may not be sufficiently addressed in the consent process and can affect eligibility for benefits such as life and disability insurance.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Gemmell LC, Jotwani A, Giordano JL, et al. Clinical implications of expanded carrier screening for pregnancy-related care and individual health. Fertil Steril. 2025. PMID: 40865753. doi:10.1016/j.fertnstert.2025.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。